Physician profile
Lori Gray
NPI 1790973964
$2,226.72
in general payments reported to CMS, 2019-2025
16 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $41.28 · 2021: $189 · 2022: $164 · 2023: $541 · 2024: $761 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,722.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $445.02 | 2023-2025 | Infuse, Lotemax Sm, Vyzulta |
| Lkc Technologies, INC. | $431.29 | 2023-2025 | |
| Alcon Vision LLC | $385.57 | 2019-2024 | Total30, Precision 1, Dailies Total1 |
| Coopervision INC. | $382.03 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Glaukos Corporation | $137.26 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $109.20 | 2021-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $100.76 | 2022-2023 | Cequa |
| Amgen INC. | $63.32 | 2024 | Tepezza |
| Visioneering Technologies, INC. | $51.89 | 2019 | |
| Dompe US, INC. | $33.80 | 2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Oyster Point Pharma, INC. | $15.51 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $15.21 | 2024 | Xdemvy |
| Abbvie INC. | $15.10 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.75 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $10.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.